Breakthrough for MS Hailed; TREATMENT: Local Therapy Centre Welcomes NewsByline: By Catherine Vonledebur HEALTH REPORTERCoventry Evening Telegraph (England)
“Although it seems obvious that your brain’s resilience to injury would determine the severity of a disease like MS, this new study has pointed us towards the key processes that underlie this resilience,” Sawcer said. Advancing Understanding and Treatment of MS To validate their findings, th...
The New York Daily News joined in, highlighting a potential “breakthrough” vaccine. Other media outlets also were using similar adjectives earlier this month. Unfortunately, it’s normal media hype. I suspect some of it was was… November 13, 2020 Columns by John Connor Of Mice and Men...
As 2024 comes to a close, Jason Hawkes, MD, MS, spoke with Dermatology Times to reflect on the advancements in treatment over the past year, as well as to look at what lies ahead in 2025. Hawkes shared his enthusiasm for the steady progression towards personalized care through variant-speci...
Treatment options have increased, over the past decade, to include first-line medication with IFN-β or glatiramer acetate for reducing relapse rate and teriflunomide for decreasing lesion activity plus the use of natalizumab, fingolimod or mitoxantrone to control breakthrough disease during initial ...
(The FDA just approved a way to enhance the body’s own immune system to attack, Lymphoma, a form of blood cancer, which has been effective in curing 85% of the patients that have received this new breakthrough treatment. It is hoped that this treatment can one day soon be developed fo...
“The broad range of research revealed through these data demonstrate our strategic approach to advancing the MS treatment landscape through new medicines and patient-focused research initiatives,” said Luciano Rossetti, Head of Global Research & Development for the biopharma business of Merck. “Much...
We explored the impact of medical service fee adjustments on the choice of medical treatment for hypertensive patients in Beijing. We hope to provide decision-making reference to promote the realization of hierarchical diagnosis and treatment in Beijing. Methods According to the framework of modeling ...
treatment of Schizophrenia[4],[5]and Parkinson’s Disease (PD) psychosis[6]. It was also clinically demonstrated that ulotaront suppressed REM (rapid eye movement) sleep parameters[7]. Ulotaront has been warranted a Breakthrough Therapy Designation by FDA for the treatment of patients with ...
These include two breakthrough drugs approved by the US FDA: Luspatercept-aamt, the first medicine approved for patients with low-risk myelodysplastic syndrome (MDS) in more than a decade; and Ozanimod, an oral medicine for the treatment of adults with relapsing forms of multiple sclerosis....